Fig. 2
From: Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
Proportion of hospitals treating at least 20% of Patients with Immunotherapy within 15 to 90 days stratified by year of diagnosis (2011–2015)
Fig. 2 | Journal for ImmunoTherapy of Cancer